Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mortality rate associated with Staphylococcus aureus prosthetic valve endocarditis (PVE) remains high. To identify clinical events associated with an increased risk of death among patients with S. aureus PVE and to evaluate the role of valve replacement surgery in reducing mortality, we conducted a retrospective cohort study of patients who met strict criteria for definite S. aureus PVE. The primary endpoint for the study was survival at 3 months from the date of diagnosis. S. aureus PVE was diagnosed in 33 patients. Of these, 14 (42%) died within 90 days of the diagnosis. Cardiac complications were detected in 22 (67%), and central nervous system (CNS) complications were detected in 11 (33%). A stepwise logistic regression multivariate model demonstrated that cardiac complications, but not CNS complications, were associated with increased mortality and that performing valve replacement surgery during antibiotic therapy was associated with decreased mortality. These associations were confirmed by using a Cox proportional hazards model with time-dependent covariates to control for survival bias. Performing valve replacement surgery during antimicrobial therapy will reduce the mortality among patients with S. aureus PVE, even those without evidence of cardiac complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus PVE, 186 especially in the presence of heart failure.”
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Prosthetic valve endocarditis.
Ivert, T. S., Dismukes, W. E., Cobbs, C. G., Blackstone, E. H., Kirklin, J. W., & Bergdahl, L. A. (1984) · Circulation · doi:10.1161/01.cir.69.2.223 · Cited by 498 · cited 1×
“7% within 60 months after surgery [1-4].”
NEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Self-citationSurgical management of infective endocarditis associated with cerebral complications
Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., & Omae, T. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70038-2 · Cited by 299
Risk factors for the development of prosthetic valve endocarditis.
Calderwood, S. B., Swinski, L. A., Waternaux, C. M., Karchmer, A. W., & Buckley, M. J. (1985) · Circulation · doi:10.1161/01.cir.72.1.31 · Cited by 271 · cited 2×
“Early PVE was defined as that occurring < 12 months after valve implantation, whereas late PVE was defined as that beginning > 12 months after valve implantation, as previously defined [2].”
MethodSelf-citationStroke in infective endocarditis.
Hart, R. G., Foster, J. W., Luther, M. F., & Kanter, M. C. (1990) · Stroke · doi:10.1161/01.str.21.5.695 · Cited by 254 · cited 1×
“aureus PVE [22-24].”
Masur, H., & Johnson, W. D. (1980) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37824-9 · Cited by 202
Valve replacement in patients with endocarditis and acute neurologic deficit
Gillinov, A. M., Shah, R. V., Curtis, W. E., Scott Stuart, R., Cameron, D. E., Baumgartner, W. A., & Greene, P. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00014-8 · Cited by 186 · cited 2×
“Recent studies have suggested that worsening of the CNS deficit may be diminished by delaying surgery for 10-14 days after cerebral infarction and for perhaps as long as 4 weeks after cerebral hemorrhage [19, 20, 25].”
BackgroundMechanisms of intracranial hemorrhage in infective endocarditis.
Hart, R. G., Kagan-Hallet, K., & Joerns, S. E. (1987) · Stroke · doi:10.1161/01.str.18.6.1048 · Cited by 186 · cited 1×
“aureus PVE [22-24].”
Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy.
Calderwood, S. B., Swinski, L. A., Karchmer, A. W., WATERNAUX, C. M., & Buckley, M. J. (1986) · PubMed · Cited by 178
Self-citationLate prosthetic valve endocarditis
Karchmer, A. W., Dismukes, W. E., Buckley, M. J., & Austen, W. G. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90046-3 · Cited by 172 · cited 3×
“In addition, it has been recognized that mortality is higher among patients with PVE caused by Staphylococcus aureus [7-9]; treatment of uncomplicated PVE caused by nonstaphylococcal, antibiotic-susceptible pathogens has been more successful [5, 9, 10].”
BackgroundResultSelf-citationProsthetic Valve Endocarditis in the ICU
Wolff, M., Witchitz, S., Chastang, C., Regnier, B., & Vachon, F. (1995) · CHEST Journal · doi:10.1378/chest.108.3.688 · Cited by 157
Prosthetic valve endocarditis: Superiority of surgical valve replacement versus medical therapy only
Yu, V. L., Fang, G. D., Keys, T. F., Harris, A. A., Gentry, L. O., FUCHS, P. C., Wagener, M. M., & Wong, E. S. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90458-8 · Cited by 145
Grover, F. L., Cohen, D. J., Oprian, C. A., Henderson, W. G., Sethi, G., & Hammermeister, K. E. (1994) · PubMed · Cited by 118
NEUROLOGICAL MANIFESTATIONS OF INFECTIVE ENDOCARDITIS: REVIEW OF CLINICAL AND THERAPEUTIC CHALLENGES
ROYDEN JONES, H., & SIEKERT, R. G. (1989) · Brain · doi:10.1093/brain/112.5.1295 · Cited by 115
Sanabria, T. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1305 · Cited by 104
Incidence and risk factors of prosthetic valve endocarditis
LRVAY, A., & LENGYEL, M. (1988) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/1010-7940(88)90009-7 · Cited by 101 · cited 1×
“7% within 60 months after surgery [1-4].”
RUTLEDGE, R., Kim, B. J., & Applebaum, R. E. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390280061013 · Cited by 92 · cited 1×
“7% within 60 months after surgery [1-4].”
Late Prosthetic Valve Endocarditis
Tornos, P., Sanz, E., Permanyer‐Miralda, G., Almirante, B., Planes, A. M., & Soler-Soler, J. (1992) · CHEST Journal · doi:10.1378/chest.101.1.37 · Cited by 75
Matsushita, K., Kuriyama, Y., Sawada, T., Yamaguchi, T., Nagata, S., Kawazoe, K., & Omae, T. (1993) · European Neurology · doi:10.1159/000116952 · Cited by 61
[Prosthetic valve endocarditis].
Almirante, B., Más, T., & Soler‐Soler, J. (1998) · PubMed · Cited by 59
Prosthetic valve endocarditis: analysis of risk factors for mortality
KUYVENHOVEN, J., VANRIJKZWIKKER, G., HERMANS, J., THOMPSON, J., & HUYSMANS, H. (1994) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/1010-7940(94)90083-3 · Cited by 58 · cited 6×
“Although some investigators have not found a difference in mortality among patients with PVE tr ated medically and those treated with medical-surgical therapy [8, 16], most studies have shown a significant reduction in mortality with medical-surgical therapy [5, 7, 9, 11], particularly among patients with S.”
BackgroundMethodResultInfluentialTreatment of Staphylococcus aureus endocarditis: An analysis based on 25 proven cases
Freeman, R., JONES, M. R., & Gould, F. K. (1986) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062122 · Cited by 6
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Treatment of Infections Associated with Surgical Implants
Darouiche, R. O. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035415 · Cited by 2,257
Metadata
- Authors
- John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-06
- Volume
- 26
- Issue
- 6
- Pages
- 1302-1309
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133760184
- Semantic Scholar
- 9d5f29d77f9c25c389602dd99ad9594bbabf8b6f
- Cited by
- 153
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 10 · 2014: 3 · 2013: 10 · 2012: 5
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Staphylococcus aureus, prosthetic valve endocarditis, mortality risk factors, valve replacement, cardiac complications, central nervous system complications, survival after diagnosis, antibiotic therapy, survivorship bias
- MeSH terms
- Adult, Aged, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Staphylococcal Infections, Cohort Studies, Prosthesis-Related Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.